ROLE OF MAGNESIUM SULPHATE IN PREVENTION OF POSTOPERATIVE PAIN IN LAPAROSCOPIC GALL BLADDER SURGERY
Not Applicable
Completed
- Conditions
- Health Condition 1: K80-K87- Disorders of gallbladder, biliary tract and pancreas
- Registration Number
- CTRI/2021/05/033417
- Lead Sponsor
- PGIMER CHANDIGARH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
) Any gender
2) 18 – 65 years of age
3) ASA-I and II patients
Exclusion Criteria
Patient refusal to participate in the study
2) Conversion to open cholecystectomy
3) Pre-existing neurological or psychiatric illness which precludes giving an informed consent
4) Pre-existing active cardiac or renal impairment ( Creatinine level > 1.5 times of normal value ) and chronic disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To evaluate the analgesic efficacy of intraperitoneal magnesium sulphate in the prevention of postoperative pain in first 24 hours after surgery among patients undergoing elective laparoscopic cholecystectomyTimepoint: start of surgery to 48 hours after surgery
- Secondary Outcome Measures
Name Time Method 1)To observe the incidence of postoperative pain <br/ ><br>2)To evaluate requirement of total dose of analgesic after surgery <br/ ><br>3)To observe the incidence of postoperative nausea and vomiting <br/ ><br>4)To observe the effect on emergence time <br/ ><br>5)To observe any postoperative adverse events related to magnesium sulfate <br/ ><br> <br/ ><br>Timepoint: start of surgery to 48 hours after surgery